IOmet Pharma Ltd

Pre-clinical drug discovery biotech with large pharma backing, operating virtual business model to advance novel treatments to clinic as rapidly as possible.

iomet pharma

IOmet Pharma is a biotechnology company, headquartered in Edinburgh, UK, focused on the early-stage discovery of novel small molecules for the treatment of cancer. Our pipeline is centred on the exciting fields of cancer immunotherapy and cancer metabolism. Since January 2016, IOmet has been a wholly-owned subsidiary of Merck & Co., Inc., (Kenilworth, NJ, USA), known as MSD outside the US and Canada. IOmet employs a business model whereby projects are initiated and actively managed by IOmet’s internal team, outsourcing  all wet laboratory work to high-quality research providers located around the globe.  Uniquely, IOmet also has access to MSD’s extensive internal drug discovery knowledge base and technology platforms. Thus, we offer the opportunity to work in an environment with the agility of a small biotech combined with the resources of large pharma. IOmet is currently in the process of expanding its team and seeks a talented, experienced and highly-motivated professional to augment its drug discovery operations.


Nine Edinburgh BioQuarter
Little France Road
EH16 4UX